Nishinomiya, Japan

Aya Konishi

This inventor holds 10 USPTO granted patents and 4 EPO patents. Top assignee: Sysmex Corporation. Active years: 2005-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aya Konishi. Retrieved from https://idiyas.com/inventor/aya-konishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Kobe, JP (2005 - 2011)
  • Nishinomiya, JP (2008 - 2018)

Company Filing History:


Years Active: 2005-2018

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Aya Konishi in Blood Analysis Technology

Introduction

Aya Konishi is a prominent inventor based in Nishinomiya, Japan. She has made significant contributions to the field of blood analysis, holding a total of 10 patents. Her work focuses on developing advanced technologies that enhance the accuracy and efficiency of blood testing.

Latest Patents

Among her latest patents are innovative devices and methods for blood analysis. One notable invention is a blood analyzer that includes a sample preparation portion designed to prepare a measurement sample free from a labeling substance. This analyzer also features a hemolytic agent that is free from a labeling substance, a light information generation portion that generates fluorescent information, and at least two types of scattered light information from the measurement sample. The control portion of this device performs a first classification of white blood cells into at least four groups: monocytes, neutrophils, eosinophils, and others, based on the fluorescent information and the scattered light information.

Another significant patent involves a blood analyzer that prepares two measurement samples. The first sample contains a blood sample and a hemolytic agent, while the second sample includes the same blood sample, the same hemolytic agent, and a staining agent. The control portion classifies white blood cells in the first measurement sample into the same four groups as mentioned earlier. Additionally, it classifies blood cells in the second measurement sample into malaria-infected red blood cells and others, utilizing

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…